The iconic Apollo Theater in Harlem is preparing to go dark for more than a year, as crews get ready to begin the venue’s first large-scale renovation in its 91-year history. Scaffolding is already up ...

(Bloomberg) -- Apollo Global Management Inc. Chief Executive Officer Marc Rowan rejected the notion that adding private assets to retirement and insurance portfolios can pose a systemic risk, calling ...

Artemis III is NASA’s mission intended to return astronauts to the moon. The plan has been to use SpaceX’s still-experimental Starship — the most powerful rocket system ever built — for the last leg ...

Apollo Global Management APO-0.47%decrease; red down pointing triangle agreed to acquire a majority stake in Spanish soccer club Atlético de Madrid, continuing a rush by private-equity firms and other ...

Giant buyout firm Apollo Global Management is telling workers to stay home on Friday as it braces for a nasty protest at its New York City headquarters – and the beef is over CEO Marc Rowan’s support ...

Apollo Global is set to report Q3 results on November 4, with shares down 24% year-to-date. Q3 is expected to be above average for all three segments of Apollo. Apollo trades within its fair value ...

GameSpot may get a commission from retail offers. Battlefield Studios has delivered on its promise to patch out Battlefield 6 Portal mode XP farms, making it so players will need to unlock things like ...

Oct 14 (Reuters) - Apollo Global Management (APO.N), opens new tab submitted a fresh bid within the last week to take pizza chain Papa John’s International (PZZA.O), opens new tab private at $64 per ...

Celebrating 20 years, the Apollo EVO redefines hypercar exclusivity with only 10 track-only units. Set for 2026 delivery, it’s a collector’s dream, reviving Apollo’s Nürburgring legacy with unmatched ...

Private equity giant Apollo Global Management is reportedly weighing a sale of AOL after receiving unsolicited bids that could value the onetime internet pioneer at around $1.5 billion. Talks are in ...

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate aced a phase 2 trial in atopic dermatitis (AD). The phase 2a study involved ...